Anupam Rama
Stock Analyst at J.P. Morgan
(4.81)
# 476
Out of 4,382 analysts
769
Total ratings
48.2%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics | Downgraded: Sell | n/a | $3.69 | - | 5 | Jun 2, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | n/a | $31.02 | - | 16 | May 31, 2026 | |
| NUVL Nuvalent | Maintained: Buy | n/a | $90.95 | - | 22 | May 31, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $54 → $53 | $45.81 | +15.70% | 19 | May 29, 2026 | |
| REPL Replimune Group | Upgraded: Hold | $8 | $9.47 | -15.52% | 31 | May 29, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $81 → $66 | $28.29 | +133.30% | 37 | May 29, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $74 → $72 | $21.91 | +228.62% | 28 | May 22, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $69 → $70 | $50.37 | +38.97% | 34 | May 22, 2026 | |
| ZLAB Zai Lab | Maintained: Buy | $27 | $16.62 | +62.45% | 21 | May 22, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | $12 → $11 | $6.70 | +64.18% | 16 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $86 | $32.29 | +166.34% | 32 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $53 | $24.27 | +118.38% | 11 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $16.60 | +80.72% | 2 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $19 | $15.75 | +20.63% | 63 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $10.31 | +404.36% | 27 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $56 | $31.05 | +80.35% | 21 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $11.97 | +92.15% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $100 | $67.61 | +47.91% | 42 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $185 | $163.88 | +12.89% | 64 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $48.42 | +48.70% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.50 | - | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.80 | - | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.27 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.29 | - | 20 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $3.00 | +300.00% | 12 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $45 | $17.34 | +159.52% | 24 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $11.26 | +68.74% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $9.92 | +222.58% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $13.16 | +203.95% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $9.49 | -36.78% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.11 | - | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.95 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $204 → $170 | $303.05 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.44 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $5 | $9.92 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $64 | $71.48 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $26 | $3.33 | n/a | 6 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $48 | $28.29 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $73.65 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $45 | $97.38 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.62 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $16.29 | n/a | 7 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $44.30 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $8.65 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.000001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $10.72 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $17.04 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.84 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $29.93 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $8 | $0.31 | n/a | 4 | Nov 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $70.97 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $137.00 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $3.31 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.95 | n/a | 4 | Jun 15, 2016 |
Fulcrum Therapeutics
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.69
Upside: -
Cogent Biosciences
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $31.02
Upside: -
Nuvalent
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $90.95
Upside: -
Travere Therapeutics
May 29, 2026
Maintained: Buy
Price Target: $54 → $53
Current: $45.81
Upside: +15.70%
Replimune Group
May 29, 2026
Upgraded: Hold
Price Target: $8
Current: $9.47
Upside: -15.52%
IDEAYA Biosciences
May 29, 2026
Maintained: Buy
Price Target: $81 → $66
Current: $28.29
Upside: +133.30%
Ultragenyx Pharmaceutical
May 22, 2026
Maintained: Buy
Price Target: $74 → $72
Current: $21.91
Upside: +228.62%
AnaptysBio
May 22, 2026
Maintained: Buy
Price Target: $69 → $70
Current: $50.37
Upside: +38.97%
Zai Lab
May 22, 2026
Maintained: Buy
Price Target: $27
Current: $16.62
Upside: +62.45%
Solid Biosciences
May 22, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $6.70
Upside: +64.18%
May 22, 2026
Maintained: Buy
Price Target: $90 → $86
Current: $32.29
Upside: +166.34%
May 22, 2026
Maintained: Buy
Price Target: $58 → $53
Current: $24.27
Upside: +118.38%
May 22, 2026
Maintained: Buy
Price Target: $31 → $30
Current: $16.60
Upside: +80.72%
May 18, 2026
Maintained: Hold
Price Target: $18 → $19
Current: $15.75
Upside: +20.63%
May 18, 2026
Maintained: Buy
Price Target: $52
Current: $10.31
Upside: +404.36%
May 13, 2026
Maintained: Buy
Price Target: $60 → $56
Current: $31.05
Upside: +80.35%
May 13, 2026
Maintained: Buy
Price Target: $23
Current: $11.97
Upside: +92.15%
May 12, 2026
Maintained: Buy
Price Target: $94 → $100
Current: $67.61
Upside: +47.91%
May 8, 2026
Rated: Buy
Price Target: $177 → $185
Current: $163.88
Upside: +12.89%
May 4, 2026
Maintained: Buy
Price Target: $68 → $72
Current: $48.42
Upside: +48.70%
Apr 13, 2026
Maintained: Buy
Price Target: n/a
Current: $7.50
Upside: -
Mar 25, 2026
Maintained: Hold
Price Target: n/a
Current: $1.80
Upside: -
Mar 24, 2026
Maintained: Sell
Price Target: n/a
Current: $1.27
Upside: -
Mar 18, 2026
Maintained: Buy
Price Target: n/a
Current: $5.29
Upside: -
Mar 16, 2026
Upgraded: Buy
Price Target: $7 → $12
Current: $3.00
Upside: +300.00%
Mar 9, 2026
Maintained: Buy
Price Target: $33 → $45
Current: $17.34
Upside: +159.52%
Mar 3, 2026
Maintained: Buy
Price Target: $19
Current: $11.26
Upside: +68.74%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $9.92
Upside: +222.58%
Dec 18, 2025
Maintained: Buy
Price Target: $40
Current: $13.16
Upside: +203.95%
Nov 18, 2025
Maintained: Sell
Price Target: $6
Current: $9.49
Upside: -36.78%
Sep 16, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.11
Upside: -
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.95
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $204 → $170
Current: $303.05
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.44
Upside: n/a
Aug 15, 2022
Maintained: Hold
Price Target: $27 → $5
Current: $9.92
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $55 → $64
Current: $71.48
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $31 → $26
Current: $3.33
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $50 → $48
Current: $28.29
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $9 → $8
Current: $73.65
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $51 → $45
Current: $97.38
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $5.62
Upside: n/a
Feb 25, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $16.29
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $55
Current: $44.30
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $8.65
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $10.72
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $17.04
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $1.84
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $7 → $6
Current: $29.93
Upside: n/a
Nov 5, 2018
Downgraded: Sell
Price Target: $18 → $8
Current: $0.31
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $70.97
Upside: n/a
Sep 29, 2017
Maintained: Hold
Price Target: n/a
Current: $137.00
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $3.31
Upside: n/a
Jun 15, 2016
Maintained: Hold
Price Target: n/a
Current: $13.95
Upside: n/a